Sara Sissy
Global Consultant Investigator COE, International
Professional Overview
Sara Sissy is an experienced global consultant and investigator with a strong track record in the pharmaceutical industry. As the Global Consultant Investigator COE at Eli Lilly and Company, she leverages her expertise in learning and development, sales and marketing, and brand management to drive impactful initiatives across diverse international markets.
Experience Summary
Current Role
In her current role as the Global Consultant Investigator COE, International at Eli Lilly and Company, Sara is responsible for leading comprehensive investigations and providing strategic consulting services to support the company's global operations. She collaborates cross-functionally to identify and mitigate risks, enhance compliance, and drive continuous improvement across the organization.
Career Progression
Prior to her current position, Sara held several leadership roles within Eli Lilly, including MEA & SAMETA Learning and Development Manager, Gulf Osteoporosis & Autoimmune Sales Manager, Gulf Osteoporosis Sales and Marketing Manager, Diabetes Brand Manager - Alliance, and Diabetes Product Specialist. Through these diverse experiences, she has developed a deep understanding of the pharmaceutical industry, with expertise in sales, marketing, brand management, and organizational learning and development.
Academic Background
Sara holds a bachelor's degree in Pharmaceutical Sciences, providing her with a strong foundation in the technical and scientific aspects of the industry.
Areas of Expertise
- Pharmaceutical industry expertise, with a focus on sales, marketing, and brand management
- Investigative and risk management skills, including comprehensive root cause analysis and strategic consulting
- Organizational learning and development, with experience in designing and implementing impactful training programs
- Cross-functional collaboration and stakeholder management
- Analytical and problem-solving capabilities
Professional Impact
Throughout her career, Sara has contributed to the growth and success of Eli Lilly's operations in various international markets. Her work has led to improved compliance, reduced risk, and enhanced organizational capabilities, ultimately driving positive outcomes for the company and its stakeholders.
Conclusion
With her extensive industry experience, investigative acumen, and proven leadership skills, Sara Sissy is a valuable asset to Eli Lilly and Company. In her current role as the Global Consultant Investigator COE, International, she continues to make a significant impact, contributing to the company's strategic objectives and driving sustainable success in the global pharmaceutical landscape.